Literature DB >> 6789496

Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.

B Lages, H J Weiss.   

Abstract

The dependence of ADP- and epinephrine-induced platelet aggregation and secretion on extracellular divalent cations was examined by quantitating these responses in citrate-, heparin-, and hirudin-anticoagulated platelet-rich plasma. ADP-induced 14C-5HT secretion in heparin-PRP and hirudin-PRP was generally decreased, relative to that in citrate-PRP, without corresponding reductions in aggregation, whereas in response to epinephrine, both aggregation and secretion were decreased in heparin-PRP, and abolished in hirudin-PRP. In heparin-PRP, but not in hirudin-PRP, the degree to which these responses were altered was highly variable among normal subjects, and was dependent on the anticoagulant concentration. Addition of citrate restored the extent of ADP-induced secretion and of epinephrine-induced aggregation and secretion in heparin-PRP to that observed in citrate-PRP, and increased the extent of ADP-induced secretion in hirudin-PRP. Addition of EDTA or EGTA, however, had no effect of ADP-induced secretion in heparin-PRP. These results suggest that ADP-induced aggregation and secretion, as well as responses to ADP vs. epinephrine, have different dependencies on extracellular or surface-bound divalent cations. The variable responses observed in heparin-PRP may reflect direct interactions of heparin with platelets, and this variability may account for the conflicting results of previous studies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6789496

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Aspirin resistance and diabetes mellitus.

Authors:  R Ajjan; R F Storey; P J Grant
Journal:  Diabetologia       Date:  2008-03       Impact factor: 10.122

2.  Historical perspective on ADP-induced platelet activation.

Authors:  Marian A Packham; Margaret L Rand
Journal:  Purinergic Signal       Date:  2011-04-02       Impact factor: 3.765

3.  Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.

Authors:  L F Brass; S J Shattil
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs.

Authors:  G Mallarkey; G M Smith
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

5.  Comparison of Two Different Blood Sample Tubes for Platelet Function Analysis with the Multiplate® System.

Authors:  Ralph M Loreth; Gudrun Klose
Journal:  Transfus Med Hemother       Date:  2010-08-13       Impact factor: 3.747

6.  Investigations of Platelet Function in Whole Blood with BAPA as Anticoagulant.

Authors:  Josephine Tabea Tauer; Judith Lohse; Silvia König; Ralf Knöfler
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

7.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.

Authors:  V M Steen; O B Tysnes; H Holmsen
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.